Dr. Paul E. Goss MD PhD FRCPC FRCP (UK)
Founder & Chief Mission Officer
Dr. Goss is a globally renowned cancer specialist with over 35 years of clinical and research experience. He graduated MD from the University of Witwatersrand in South Africa, obtained a Ph.D. in cancer research from the University of London, and has practiced in London, Toronto, and Boston. Dr. Goss has personally cared for over 7000 cancer patients and designed and spearheaded clinical trials involving over 25,000 cancer patients in more than 55 countries. Dr. Goss is also a global cancer control expert having led multi-national teams of researchers to examine the state of cancer control in over half the world’s population including Latin America, China, India, and Russia. He has over 250 publications in leading international journals on cancer research and cancer control.
Chairman of the Board
Andrea Jung is the current President and CEO of Grameen America and is dedicated to scaling the organization’s ability to solve economic issues for women and families across the US. She was previously the Chairman and CEO of Avon Products, Inc. She is also a member of the Board of Directors for General Electric, Daimler AG, and Apple, Inc. and a contributor to the Committee for Economic Development, an independent, nonprofit American think tank. She graduated from Princeton University.
F. Daniel Haley
Dan Haley is currently President and CEO of Bradford Networks Inc. Dan has over 35 years of experience in the high-tech industry. He has been the CEO of four start-ups and also was a General Partner with Advent International Global Private Equity. He spent the early part of his career in various technical roles at Digital Equipment Corporation. He has a BS from the University of Massachusetts and an MBA from the University of Denver.
Paul Damp has been the Managing Partner of Kestrel Capital Partners and Non-Executive Chairman since 1994, in addition to being the director of Davis & Henderson Corporation. He is currently on the board of the Women’s College Hospital Foundation in Toronto. He is a graduate of the University of Toronto.
Kevin Honeycutt is the CEO and President of the Alliance for Cancer Gene Therapy where his principal role is to enhance the vision of ACGT and to spearhead ACGT’s current focus on funding the next generation of challenges brought by metastatic cancers and solid tumors. Prior to his role at ACGT, Mr. Honeycutt was the President and CEO of the Avon Breast Cancer Crusade and served as Executive Director of the Avon Foundation for Women. As founder and consultant of Honeycutt Partners, his clients included the American Diabetes Association, the Entertainment Industry Foundation, and the San Francisco AIDS Foundation. Mr. Honeycutt serves on the Board of Directors of Friends of Mozart. He is a past Board member of the UCLA Jonsson Cancer Center Foundation.
Mario Maffei served as Vice-Consul of Panama in Philadelphia. Later became Plant Manager/Vice-President of Clairol, Inc. / Vantage House, divisions of Bristol Myers. Since 1980 has been President and CEO of Verla International Ltd. Member of the International Advisory Board for the Panama Canal. Past board member and Finance Committee Chair for George Jackson Academy in New York City. Mario holds a BS degree in Industrial Engineering and an MBA, both from Lehigh University.
Dr. Tabaré Vázquez
Honorary Board Member
Dr. Tabaré Vázquez (1940 – 2020), was president of Uruguay between 2005 – 2010 and 2015 – 2020. He was also a prominent professor of oncology. During his first presidency, he introduced several important policies related to cancer prevention such as stringent tobacco control which he established as a health policy in Uruguay in 2005. This legislation is considered pioneering in cancer prevention in Uruguay, Latin America, and worldwide. President Vázquez was highly regarded and connected to health policymakers throughout Latin America.